‘GREEN IS THE NEW BLACK’

BudzCorp is a start-up business in the field of marijuana/cannabis production, processing and distribution.

Learn More

Our support team is available 24/7 to resolve any product issues

Phone number+34-923-445-012
media

Purple Hawaiian Haze

Known for its potential to alleviate symptoms of depression, anxiety, and chronic pain while providing a boost in energy and creativity.

  • Sativa-Dominant
  • THC 110.0-160.0mg/g
  • CBD 0.0-1.0mg/g
About
media

Sour Diesel

Sour Diesel is known for its cerebral and energizing effects, making it a great choice for patients looking for a boost in focus and productivity.

  • Sativa-Dominant
  • THC 110.0-160.0mg/g
  • CBD 0.0-1.0mg/g
About
media

Northern Lights

Patients often report feeling relaxed and sedated after using Northern Lights, making it a popular strain for nighttime use.

  • Sativa-Dominant
  • THC 110.0-160.0mg/g
  • CBD 0.0-1.0mg/g
About

BudzCorp, as an operational commercial enterprise, was evaluated by ALGOS101 and achieved a commercial success rate evaluation of 89.03%

The business model of BudzCorp includes a Hydroponic / Aquaponic Double Root Farming Operation and processing laboratory with appropriate jurisdictional licensing and defined logistical distribution systems. The primary development and production operations of the BudzCorp business model will be in Andalucía, Southern Spain. BudzCorp is wholly owned by Solalgo’s holding company Cubex Investments Limited

media
  • 0

    The global legal marijuana market size was value in 2022

  • 0

    Expected expansion at a compound annual growth rate (CAGR) from 2023 to 2030

CBD Facial Serum: Anti-Aging + Daily Moisturizer
Sector Analytics: Global marijuana chart

The global legal marijuana market size was valued at $16.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.4% from 2023 to 2030. The growing demand for legal marijuana has been a primary factor in the growth of the market.
Medical marijuana and its derivatives can be used to treat symptoms of various diseases;

  • Chronic Pain
  • Cancer
  • Depression and Anxiety
  • Arthritis
  • Diabetes
  • Glaucoma
  • Migraines
  • Epilepsy
  • Multiple Sclerosis
  • AIDS
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s
  • Post-traumatic Stress Disorder (PTSD)
  • Parkinson's
  • Tourette’s
deco
deco

Governmental medical and drug licensing authorities globally accept marijuana derivatives for the prescription of diseases generating a quick turnaround of its legal status in most countries

Growth and Potential of North American Cannabis Market

North America (U.S. and Canada) have sanctioned the use of recreational marijuana with more than two-thirds of U.S. states legalizing the cultivation, processing, distribution and sale of marijuana and its derivatives.

Our Products
media

  • The legalized use of medical marijuana has the effect of reducing import of the product allowing for controlled revenue in the form of taxes - also providing the benefit of generating employment. In 2022, the marijuana oil and tinctures segment held the largest revenue share of over 53.2% and are anticipated to register the fastest growth rate of 26.1%.

  • Marijuana oil and tinctures are being studied extensively for multiple medical indications in over 80% of sovereign jurisdictions. The medical segment of the global marijuana market had the largest revenue share of over 82.6% in 2022. The growth in this segment can be attributed to the recent legalization and decriminalization of marijuana for medical use

  • With an increase in awareness surrounding the use of medical cannabis and its derivatives, the market is expected to grow exponentially over the forecast period. The primary companies to establish their presence in the Spanish / European markets are expected to capitalize by increasing regional presence and consolidating market share.